JPRN-jRCT2080221181未知2 期
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
ovartis Pharma K.K.0 个研究点开始时间: 2010年8月5日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients who completed the core study ( A Multicenter Trial of Subcutaneously Administered AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis)
排除标准
- •-Patients who experience a second consecutive full relapse at visit 13 of the core study ( A Multicenter Trial of Subcutaneously Administered AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis)
- •Other protocol-defined inclusion/exclusion criteria may apply
研究者
相似试验
进行中（未招募）
1 期
A multicenter extension trial of subcutaneously administered AIN457 in patients with moderate to severe chronic plaque-type psoriasis - A2211E1EUCTR2009-017234-51-ISovartis Pharma Services AG250
进行中（未招募）
1 期
A study where patients affected by moderate to severe chronic plaque-type psoriasis receive AIN457 subcutaneouslyModerate to severe plaque-type psoriasisMedDRA version: 14.1Level: LLTClassification code 10050576Term: Psoriasis vulgarisSystem Organ Class: 100000004858EUCTR2009-017234-51-DEovartis Pharma Services AG275
进行中（未招募）
1 期
A multicenter extension trial of subcutaneously administered AIN457 in patients with moderate to severe chronic plaque-type psoriasismoderate to severe chronic plaque-type psoriasisMedDRA version: 12.1Level: LLTClassification code 10050576Term: Psoriasis vulgarisEUCTR2009-017234-51-FRovartis Pharma Services AG275
进行中（未招募）
1 期
A multicenter extension trial of subcutaneously administered AIN457 in patients with moderate to severe chronic plaque-type psoriasis - A2211E1EUCTR2009-017234-51-NOovartis Pharma Services AG275
进行中（未招募）
1 期
An Extension Study in Patients with Moderate or Severe Hemophilia A or B who have Participated in a Previous Clinical Study with FitusiraHemophilia A or Hemophilia BMedDRA version: 20.0 Level: LLT Classification code 10060613 Term: Hemophilia A (Factor VIII) System Organ Class: 100000004850MedDRA version: 20.0 Level: LLT Classification code 10060614 Term: Hemophilia B (Factor IX) System Organ Class: 100000004850EUCTR2015-001395-21-GBGenzyme Corporation48